It’s not a proven scientific fact, but many pot smokers are consuming mangoes an hour before lighting up to boost their highs. According to Marijuana.com, there’s a good chance that the myrcene molecules found in mango can possibly “increase, strengthen and even lengthen” the euphoric feeling from smoking marijuana. Marijuana already contains more than 100 terpene molecules that are responsible for affecting THC in the brain and giving highs their ebbs and flows. But marijuana contains the myrcene terpene more than any other kind. So, if you eat a mango rich in myrcenes, you can potentially improve the high for low-quality…
Author: WebTeam
On the afternoon of Wednesday July 2nd, 2014, it was announced that Spong Lawyers had achieved an important victory in the high court of The Hague, in a process regarding the supplies of several coffeeshops. These shops were represented by lawyers Gerard Spong, Sidney Smeets and Tim Vis. This victory declares the prosecution of three coffeeshops by the Public Prosecution Service as being inadmissible by The Hague court, due to the supply system being via the so-called ‘back door’. The court has ruled that there is no interest in criminal prosecution, and furthermore denied the Prosecution their right to prosecute.…
A study published recently in the International Journal of High Risk Behavior and Addiction, and published online by the U.S. National Institute of Health, has found that cannabinoids may treat the symptoms of a large variety of neurodegernative diseases including multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, Parkinson’s disease and Alzheimer’s disease. “The aim of this review is to highlight the role of endocannabinoid system in neurodegenerative diseases”, claims the abstract of the study, which researchers call “a critical analysis of the most recent data currently present in scientific literature on the subject; a qualitative synthesis of only the most…
Toronto, Canada: Subjects who regularly inhale cannabis smoke possess no greater risk of contracting lung cancer than do those who consume it occasionally or not at all, according to data published online ahead of print in the International Journal of Cancer. An international team of investigators from Canada, New Zealand, Great Britian, and the United States analyzed data from six case-control studies involving over 5,000 subjects (2,159 cases and 2,985 controls) from around the world. Authors concluded, “Results from our pooled analyses provide little evidence for an increased risk of lung cancer among habitual or long-term cannabis smokers.” The team…
A large portion of cancer patients who try medical marijuana find it highly effective for symptom relief, a new survey shows. One of marijuana’s most accepted benefits is the treatment of symptoms associated with cancer and cancer chemotherapy. Marinol, a synthetic THC pill, has been available to cancer patients since the 1980s, and a number of countries now allow the use of cannabis in its natural form. However, no controlled study has evaluated the benefits of medical marijuana for patients with cancer. In order to shed some light on its use, a group of Israeli doctors conducted a survey among…
A-beta, a substance suspected as a prime culprit in Alzheimer’s disease, may start impairing learning and memory long before plaques form in the brain. A new study led by investigators at the Stanford University School of Medicine has implicated the blocking of endocannabinoids — signaling substances that are the brain’s internal versions of the psychoactive chemicals in marijuana and hashish — in the early pathology of Alzheimer’s disease. A substance called A-beta — strongly suspected to play a key role in Alzheimer’s because it’s the chief constituent of the hallmark clumps dotting the brains of people with Alzheimer’s — may,…
June 26th is a Global Day of Action for the international #supportdontpunish campaign to raise awareness about the harms and increased health problems caused by the prohibition of drugs. Please join us at Belfast City Hall, 11:30am on Thursday 26th June for a short time to show your support for the global drug policy reform and meet members active in drug policy reform and get involved with SSDP. Most of our political ‘leaders’ are afraid to talk about #nomoredrugwar in fear of being too “soft about drugs”. Our campaign attempts to challenge that school of thought and encourage a paradigm…
London, UK; 17 June 2014: GW Pharmaceuticals a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with GW’s investigational cannabidiol (CBD) product candidate, Epidiolex®, for a period of 12 weeks. The treatment-resistant patients suffer from a range of epilepsies in which current anti-epileptic drugs have been unsuccessful in adequately controlling seizures, and included such severe forms of epilepsy as Dravet syndrome and Lennox-Gastaut syndrome. Uncontrolled data from two hospital sites…
A nearly 10-year long study conducted by researchers at California Pacific Medical Center’s Research Institute, and published this month by the British Journal of Pharmacology, has found that cannabinoids can combat breast cancer progression. “The psychoactive cannabinoid Δ9 -tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression each through distinct antitumor pathways”, begins the study’s abstract. “Our goal was to discover a compound that could efficiently target both cannabinoid antitumor pathways.” While conducting the study, researchers found that cannabidiol reduced breast cancer metastasis by up to 75% in mice; “CBD reduced breast cancer metastasis in advanced…
Oslo, Norway: The detection of THC in oral fluid is not necessarily indicative of recent cannabis exposure, according to clinical trial data published in the journal Therapeutic Drug Monitoring. Investigators assessed the detection time of THC in oral fluid in habitual cannabis consumers during a prolonged period of monitored abstinence. Researchers collected oral fluid samples twice per day for the length of the trial. Authors identified that THC may be detectable in subjects’ oral fluid samples for a period of up to eight days following cannabis exposure. Subjects’ oral THC levels fluctuated from negative to positive results during this period…
